PB2 is one of the subunits of the influenza virus heterotrimeric polymerase. By its cap-binding domain (PB2cap), PB2 captures the 5 cap of the host pre-mRNA to generate a capped 5 oligonucleotide primer for virus transcription. The crystal structure of influenza A virus H3N2 PB2cap with bound cap analogue m7GTP has been reported previously. To show the substrate-free structural details of PB2cap and clarify whether obvious conformational changes exist between the substrate-free and substrate-bound cap-binding domain, we have successfully obtained the crystal of substrate-free H1N1 PB2cap. The crystal of H1N1 PB2cap diffracted to a high resolution of 1.32 angstrom. The crystal symmetry belongs to space group P1 with unit-cell parameters a = ...
Influenza viruses are segmented, negative-sense RNA viruses responsible for influenza disease. Unlik...
Influenza viruses are segmented, negative-sense RNA viruses responsible for influenza disease. Unlik...
RNA polymerases of human influenza viruses A, B and C do not have a capping enzyme, as other RNA vir...
X-ray crystallographic structural determinations of the PB2 cap binding domain (PB2cap) have improve...
X-ray crystallographic structural determinations of the PB2 cap binding domain (PB2cap) have improve...
The influenza RNA-dependent RNA polymerase is a core enzyme required for both transcription and repl...
The RNA polymerase of influenza virus consists of three subunits: PA, PB1 and PB2. It uses a unique ...
Influenza virus uses a unique mechanism to initiate viral transcription named cap-snatching. The PB2...
Influenza virus RNA-dependent RNA polymerase is a heterotrimer composed of PA, PB1, and PB2 subunits...
The influenza virus RNA polymerase is a heterotrimeric complex of PA, PB1, and PB2. PB1 functions in...
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirabl...
The influenza virus causes a disease that kills approximately 500,000 people worldwide each year. In...
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirabl...
<div><p>It is generally recognised that novel antiviral drugs, less prone to resistance, would be a ...
The influenza virus causes a disease that kills approximately 500,000 people worldwide each year. In...
Influenza viruses are segmented, negative-sense RNA viruses responsible for influenza disease. Unlik...
Influenza viruses are segmented, negative-sense RNA viruses responsible for influenza disease. Unlik...
RNA polymerases of human influenza viruses A, B and C do not have a capping enzyme, as other RNA vir...
X-ray crystallographic structural determinations of the PB2 cap binding domain (PB2cap) have improve...
X-ray crystallographic structural determinations of the PB2 cap binding domain (PB2cap) have improve...
The influenza RNA-dependent RNA polymerase is a core enzyme required for both transcription and repl...
The RNA polymerase of influenza virus consists of three subunits: PA, PB1 and PB2. It uses a unique ...
Influenza virus uses a unique mechanism to initiate viral transcription named cap-snatching. The PB2...
Influenza virus RNA-dependent RNA polymerase is a heterotrimer composed of PA, PB1, and PB2 subunits...
The influenza virus RNA polymerase is a heterotrimeric complex of PA, PB1, and PB2. PB1 functions in...
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirabl...
The influenza virus causes a disease that kills approximately 500,000 people worldwide each year. In...
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirabl...
<div><p>It is generally recognised that novel antiviral drugs, less prone to resistance, would be a ...
The influenza virus causes a disease that kills approximately 500,000 people worldwide each year. In...
Influenza viruses are segmented, negative-sense RNA viruses responsible for influenza disease. Unlik...
Influenza viruses are segmented, negative-sense RNA viruses responsible for influenza disease. Unlik...
RNA polymerases of human influenza viruses A, B and C do not have a capping enzyme, as other RNA vir...